The role of blood rheology in sickle cell disease

Blood Reviews

Volumn 30, Issue 2, 2016, Pages 111-118

  Connes, Philippe ^a,b,c,d   Alexy, Tamas ^e,f   Detterich, Jon ^g   Romana, Marc ^a,b   Hardy Dessources, Marie Dominique ^a,b   Ballas, Samir K ^h  

^a Centre Hospitalier Universitaire Pointe a Pitre   (Guadeloupe)

^b Laboratory of Excellence GR Ex 'The red cell from genesis to death' PRES Sorbonne Paris Cité   (France)

^c INSTITUT UNIVERSITAIRE DE FRANCE   (France)

^d UNIVERSITÉ LYON 1   (France)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f ATLANTA VA MEDICAL CENTER   (United States)

^g CHILDREN S HOSPITAL LOS ANGELES   (United States)

^h THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Blood viscosity; Red blood cell aggregation; Red blood cell deformability; Sickle cell disease; Vaso occlusive crises

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBRINOGEN; HEMOGLOBIN F; NITRIC OXIDE SYNTHASE;

ACUTE CHEST SYNDROME; ACUTE PAIN CRISIS; ALPHA THALASSEMIA; ARTICLE; BLOOD RHEOLOGY; BLOOD VISCOSITY; BLOOD VOLUME; BONE NECROSIS; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; GENE DELETION; GLOMERULOPATHY; HEMOGLOBIN BLOOD LEVEL; HUMAN; LEG ULCER; MICROCIRCULATION; OXIDATIVE STRESS; PAIN; PATHOPHYSIOLOGY; PHENOTYPE; PRIAPISM; PRIORITY JOURNAL; RETINOPATHY; RISK FACTOR; SICKLE CELL ANEMIA; STEADY STATE; VASOOCCLUSIVE CRISIS; VEIN OCCLUSION; VISCOELASTICITY; BLOOD; BLOOD CLOTTING; COMPLICATION; GENETICS; HEMATOCRIT; HEMOLYSIS; METABOLISM; MUTATION; PROGNOSIS;

ANEMIA, SICKLE CELL; BLOOD COAGULATION; BLOOD VISCOSITY; ERYTHROCYTE DEFORMABILITY; HEMATOCRIT; HEMOLYSIS; HEMORHEOLOGY; HUMANS; MUTATION; OXIDATIVE STRESS; PROGNOSIS;

EID: 84940704594     PISSN: 0268960X     EISSN: 15321681     Source Type: Journal    
DOI: 10.1016/j.blre.2015.08.005     Document Type: Article

References (111)

1. Weatherall D.J. The inherited diseases of hemoglobin are an emerging global health burden. Blood 2010, 115:4331-4336.
2. Embury S.H. The clinical pathophysiology of sickle cell disease. Annu Rev Med 1986, 37:361-376.
3. Hirsch R.E., Raventos-Suarez C., Olson J.A., Nagel R.L. Ligand state of intraerythrocytic circulating HbC crystals in homozygote CC patients. Blood 1985, 66:775-777.
4. Lin M.J., Nagel R.L., Hirsch R.E. Acceleration of hemoglobin C crystallization by hemoglobin S. Blood 1989, 74:1823-1825.
5. Hannemann A., Weiss E., Rees D.C., Dalibalta S., Ellory J.C., Gibson J.S. The properties of red blood cells from patients heterozygous for HbS and HbC (HbSC genotype). Anemia 2011, 2011.
6. Nagel R.L., Fabry M.E., Steinberg M.H. The paradox of hemoglobin SC disease. Blood Rev 2003, 17:167-178.
7. Lionnet F., Hammoudi N., Stojanovic K.S., Avellino V., Grateau G., Girot R., et al. Hemoglobin sickle cell disease complications: a clinical study of 179 cases. Haematologica 2012, 97:1136-1141.
8. Chien S., Usami S., Bertles J.F. Abnormal rheology of oxygenated blood in sickle cell anemia. J Clin Invest 1970, 49:623-634.
9. Baskurt O.K., Meiselman H.J. Blood rheology and hemodynamics. Semin Thromb Hemost 2003, 29:435-450.
10. Vent-Schmidt J., Waltz X., Romana M., Hardy-Dessources M.D., Lemonne N., Billaud M., et al. Blood thixotropy in patients with sickle cell anaemia: role of haematocrit and red blood cell rheological properties. PLoS One 2014, 9.
11. Tsai A.G., Acero C., Nance P.R., Cabrales P., Frangos J.A., Buerk D.G., et al. Elevated plasma viscosity in extreme hemodilution increases perivascular nitric oxide concentration and microvascular perfusion. Am J Physiol Heart Circ Physiol 2005, 288:H1730-H1739.
12. Chien S. Red cell deformability and its relevance to blood flow. Annu Rev Physiol 1987, 49:177-192.
13. Baskurt O.K., Meiselman H.J. RBC aggregation: more important than RBC adhesion to endothelial cells as a determinant of in vivo blood flow in health and disease. Microcirculation 2008, 15:585-590.
14. Rampling M.W., Meiselman H.J., Neu B., Baskurt O.K. Influence of cell-specific factors on red blood cell aggregation. Biorheology 2004, 41:91-112.
15. Tripette J., Alexy T., Hardy-Dessources M.D., Mougenel D., Beltan E., Chalabi T., et al. Red blood cell aggregation, aggregate strength and oxygen transport potential of blood are abnormal in both homozygous sickle cell anemia and sickle-hemoglobin C disease. Haematologica 2009, 94:1060-1065.
16. Alexy T., Pais E., Armstrong J.K., Meiselman H.J., Johnson C.S., Fisher T.C. Rheologic behavior of sickle and normal red blood cell mixtures in sickle plasma: implications for transfusion therapy. Transfusion 2006, 46:912-918.
17. Alexy T., Sangkatumvong S., Connes P., Pais E., Tripette J., Barthelemy J.C., et al. Sickle cell disease: selected aspects of pathophysiology. Clin Hemorheol Microcirc 2010, 44:155-166.
18. Waltz X., Hardy-Dessources M.D., Lemonne N., Mougenel D., Lalanne-Mistrih M.L., Lamarre Y., et al. Is there a relationship between the hematocrit-to-viscosity ratio and microvascular oxygenation in brain and muscle?. Clin Hemorheol Microcirc 2015, 59:37-43.
19. Vent-Schmidt J., Waltz X., Pichon A., Hardy-Dessources M.D., Romana M., Connes P. Indirect viscosimetric method is less accurate than ektacytometry for the measurement of red blood cell deformability. Clin Hemorheol Microcirc 2015, 59:115-121.
20. Waltz X., Hedreville M., Sinnapah S., Lamarre Y., Soter V., Lemonne N., et al. Delayed beneficial effect of acute exercise on red blood cell aggregate strength in patients with sickle cell anemia. Clin Hemorheol Microcirc 2012, 52:15-26.
21. Connes P., Lamarre Y., Waltz X., Ballas S.K., Lemonne N., Etienne-Julan M., et al. Haemolysis and abnormal haemorheology in sickle cell anaemia. Br J Haematol 2014, 165:564-572.
22. Bucherer C., Ladjouzi J., Lacombe C., Lelievre J.C., Vandewalle H., Beuzard Y., et al. Effect of deoxygenation on rheological behavior of density separated sickle cell suspensions. Clin Hemorheol 1992, 12:415-425.
23. Ballas S.K., Mohandas N. Sickle red cell microrheology and sickle blood rheology. Microcirculation 2004, 11:209-225.
24. Ballas S.K., Smith E.D. Red blood cell changes during the evolution of the sickle cell painful crisis. Blood 1992, 79:2154-2163.
25. Rieber E.E., Veliz G., Pollack S. Red cells in sickle cell crisis: observations on the pathophysiology of crisis. Blood 1977, 49:967-979.
26. Kenny M.W., Meakin M., Worthington D.J., Stuart J. Erythrocyte deformability in sickle-cell crisis. Br J Haematol 1981, 49:103-109.
27. Ballas S.K. Treatment of pain in adults with sickle cell disease. Am J Hematol 1990, 34:49-54.
28. Clark M.R., Mohandas N., Shohet S.B. Deformability of oxygenated irreversibly sickled cells. J Clin Invest 1980, 65:189-196.
29. Lawrence C., Fabry M.E. Erythrocyte sedimentation rate during steady state and painful crisis in sickle cell anemia. Am J Med 1986, 81:801-808.
30. Awodu O.A., Famodu A.A., Ajayi O.I., Enosolease M.E., Olufemi O.Y., Olayemi E. Using serial haemorheological parameters to assess clinical status in sickle cell anaemia patients in vaso-occlussive crisis. Clin Hemorheol Microcirc 2009, 41:143-148.
31. Akinola N.O., Stevens S.M., Franklin I.M., Nash G.B., Stuart J. Rheological changes in the prodromal and established phases of sickle cell vaso-occlusive crisis. Br J Haematol 1992, 81:598-602.
32. Richardson S.G., Matthews K.B., Stuart J., Geddes A.M., Wilcox R.M. Serial changes in coagulation and viscosity during sickle-cell crisis. Br J Haematol 1979, 41:95-103.
33. Gladwin M.T., Vichinsky E. Pulmonary complications of sickle cell disease. N Engl J Med 2008, 359:2254-2265.
34. Kato G.J., Gladwin M.T., Steinberg M.H. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev 2007, 21:37-47.
35. Connes P., Verlhac S., Bernaudin F. Advances in understanding the pathogenesis of cerebrovascular vasculopathy in sickle cell anaemia. Br J Haematol 2013, 161:484-498.
36. Camus S.M., Gausseres B., Bonnin P., Loufrani L., Grimaud L., Charue D., et al. Erythrocyte microparticles can induce kidney vaso-occlusions in a murine model of sickle cell disease. Blood 2012, 120:5050-5058.
37. Liu C., Zhao W., Christ G.J., Gladwin M.T., Kim-Shapiro D.B. Nitric oxide scavenging by red cell microparticles. Free Radic Biol Med 2013, 65:1164-1173.
38. Kato G.J., Martyr S., Blackwelder W.C., Nichols J.S., Coles W.A., Hunter L.A., et al. Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality. Br J Haematol 2005, 130:943-953.
39. Lin E.E., Rodgers G.P., Gladwin M.T. Hemolytic anemia-associated pulmonary hypertension in sickle cell disease. Curr Hematol Rep 2005, 4:117-125.
40. Reiter C.D., Wang X., Tanus-Santos J.E., Hogg N., Cannon R.O., Schechter A.N., et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 2002, 8:1383-1389.
41. Bunn H.F., Nathan D.G., Dover G.J., Hebbel R.P., Platt O.S., Rosse W.F., et al. Pulmonary hypertension and nitric oxide depletion in sickle cell disease. Blood 2010, 116:687-692.
42. Gladwin M.T., Sachdev V., Jison M.L., Shizukuda Y., Plehn J.F., Minter K., et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 2004, 350:886-895.
43. Nebor D., Broquere C., Brudey K., Mougenel D., Tarer V., Connes P., et al. Alpha-thalassemia is associated with a decreased occurrence and a delayed age-at-onset of albuminuria in sickle cell anemia patients. Blood Cells Mol Dis 2010, 45:154-158.
44. Bowers A.S., Reid H.L., Greenidge A., Landis C., Reid M. Blood viscosity and the expression of inflammatory and adhesion markers in homozygous sickle cell disease subjects with chronic leg ulcers. PLoS One 2013, 8.
45. Bernaudin F., Verlhac S., Chevret S., Torres M., Coic L., Arnaud C., et al. G6PD deficiency, absence of alpha-thalassemia, and hemolytic rate at baseline are significant independent risk factors for abnormally high cerebral velocities in patients with sickle cell anemia. Blood 2008, 112:4314-4317.
46. DeBaun M.R., Sarnaik S.A., Rodeghier M.J., Minniti C.P., Howard T.H., Iyer R.V., et al. Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure. Blood 2012, 119:3684-3690.
47. Lamarre Y., Romana M., Lemonne N., Hardy-Dessources M.D., Tarer V., Mougenel D., et al. Alpha thalassemia protects sickle cell anemia patients from macro-albuminuria through its effects on red blood cell rheological properties. Clin Hemorheol Microcirc 2014, 57:63-72.
48. Connes P., Lamarre Y., Hardy-Dessources M.D., Lemonne N., Waltz X., Mougenel D., et al. Decreased hematocrit-to-viscosity ratio and increased lactate dehydrogenase level in patients with sickle cell anemia and recurrent leg ulcers. PLoS One 2013, 8.
49. Bartolucci P., Brugnara C., Teixeira-Pinto A., Pissard S., Moradkhani K., Jouault H., et al. Erythrocyte density in sickle cell syndromes is associated with specific clinical manifestations and hemolysis. Blood 2012, 120:3136-3141.
50. Platt O.S., Thorington B.D., Brambilla D.J., Milner P.F., Rosse W.F., Vichinsky E., et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 1991, 325:11-16.
51. Castro O., Brambilla D.J., Thorington B., Reindorf C.A., Scott R.B., Gillette P., et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. The cooperative study of sickle cell disease. Blood 1994, 84:643-649.
52. Lande W.M., Andrews D.L., Clark M.R., Braham N.V., Black D.M., Embury S.H., et al. The incidence of painful crisis in homozygous sickle cell disease: correlation with red cell deformability. Blood 1988, 72:2056-2059.
53. Nebor D., Bowers A., Hardy-Dessources M.D., Knight-Madden J., Romana M., Reid H., et al. Frequency of pain crises in sickle cell anemia and its relationship with the sympatho-vagal balance, blood viscosity and inflammation. Haematologica 2011, 96:1589-1594.
54. Lamarre Y., Romana M., Waltz X., Lalanne-Mistrih M.L., Tressieres B., Divialle-Doumdo L., et al. Hemorheological risk factors of acute chest syndrome and painful vaso-occlusive crisis in children with sickle cell disease. Haematologica 2012, 97:1641-1647.
55. Lamarre Y., Hardy-Dessources M.D., Romana M., Lalanne-Mistrih M.L., Waltz X., Petras M., et al. Relationships between systemic vascular resistance, blood rheology and nitric oxide in children with sickle cell anemia or sickle cell-hemoglobin C disease. Clin Hemorheol Microcirc 2014, 58:307-316.
56. Mohan J.S., Lip G.Y., Blann A.D., Bareford D., Marshall J.M. Endothelium-dependent and endothelium-independent vasodilatation of the cutaneous circulation in sickle cell disease. Eur J Clin Invest 2011, 41:546-551.
57. Lemaire C., Lamarre Y., Lemonne N., Waltz X., Chahed S., Cabot F., et al. Severe proliferative retinopathy is associated with blood hyperviscosity in sickle cell hemoglobin-C disease but not in sickle cell anemia. Clin Hemorheol Microcirc 2013, 55:205-212.
58. Lemonne N., Lamarre Y., Romana M., Hardy-Dessources M.D., Lionnet F., Waltz X., et al. Impaired blood rheology plays a role in the chronic disorders associated with sickle cell-hemoglobin C disease. Haematologica 2014, 99:74-75.
59. Rosse W.F., Narla M., Petz L.D., Steinberg M.H. New views of sickle cell disease pathophysiology and treatment. Hematology Am Soc Hematol Educ Program 2000, 2-17.
60. Lemonne N., Lamarre Y., Romana M., Mukisi-Mukaza M., Hardy-Dessources M.D., Tarer V., et al. Does increased red blood cell deformability raise the risk for osteonecrosis in sickle cell anemia?. Blood 2013, 121:3054-3056.
61. Milner P.F., Kraus A.P., Sebes J.I., Sleeper L.A., Dukes K.A., Embury S.H., et al. Sickle cell disease as a cause of osteonecrosis of the femoral head. N Engl J Med 1991, 325:1476-1481.
62. Ballas S.K. Sickle cell anemia with few painful crises is characterized by decreased red cell deformability and increased number of dense cells. Am J Hematol 1991, 36:122-130.
63. Ballas S.K., Larner J., Smith E.D., Surrey S., Schwartz E., Rappaport E.F. Rheologic predictors of the severity of the painful sickle cell crisis. Blood 1988, 72:1216-1223.
64. Kaul D.K., Fabry M.E. In vivo studies of sickle red blood cells. Microcirculation 2004, 11:153-165.
65. Mohandas N., Evans E. Rheological and adherence properties of sickle cells. Potential contribution to hematologic manifestations of the disease. Ann N Y Acad Sci 1989, 565:327-337.
66. Steinberg M.H. Predicting clinical severity in sickle cell anaemia. Br J Haematol 2005, 129:465-481.
67. Guasch A., Zayas C.F., Eckman J.R., Muralidharan K., Zhang W., Elsas L.J. Evidence that microdeletions in the alpha globin gene protect against the development of sickle cell glomerulopathy in humans. J Am Soc Nephrol 1999, 10:1014-1019.
68. Joly P., Garnier N., Kebaili K., Griffon-Renoux C., Dony A., Cheikh N., et al. G6PD deficiency and absence of α-thalassaemia increase the risk for cerebral vasculopathy in children with sickle cell anaemia. Eur J Haematol Jun13 2015, 10.1111/ejh.12607.
69. Higgs D.R., Aldridge B.E., Lamb J., Clegg J.B., Weatherall D.J., Hayes R.J., et al. The interaction of alpha-thalassemia and homozygous sickle-cell disease. N Engl J Med 1982, 306:1441-1446.
70. Koshy M., Entsuah R., Koranda A., Kraus A.P., Johnson R., Bellvue R., et al. Leg ulcers in patients with sickle cell disease. Blood 1989, 74:1403-1408.
71. Nolan V.G., Wyszynski D.F., Farrer L.A., Steinberg M.H. Hemolysis-associated priapism in sickle cell disease. Blood 2005, 106:3264-3267.
72. Embury S.H., Clark M.R., Monroy G., Mohandas N. Concurrent sickle cell anemia and alpha-thalassemia. Effect on pathological properties of sickle erythrocytes. J Clin Invest 1984, 73:116-123.
73. Steinberg M.H., Rosenstock W., Coleman M.B., Adams J.G., Platica O., Cedeno M., et al. Effects of thalassemia and microcytosis on the hematologic and vasoocclusive severity of sickle cell anemia. Blood 1984, 63:1353-1360.
74. Ballas S.K., Talacki C.A., Rao V.M., Steiner R.M. The prevalence of avascular necrosis in sickle cell anemia: correlation with alpha-thalassemia. Hemoglobin 1989, 13:649-655.
75. Nagel R.L., Labie D. The consequences and implications of the multicentric origin of the Hb S gene. Prog Clin Biol Res 1985, 191:93-103.
76. Powars D.R., Meiselman H.J., Fisher T.C., Hiti A., Johnson C. Beta-S gene cluster haplotypes modulate hematologic and hemorheologic expression in sickle cell anemia. Use in predicting clinical severity. Am J Pediatr Hematol Oncol 1994, 16:55-61.
77. Platt O.S., Brambilla D.J., Rosse W.F., Milner P.F., Castro O., Steinberg M.H., et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994, 330:1639-1644.
78. Perrine R.P., Pembrey M.E., John P., Perrine S., Shoup F. Natural history of sickle cell anemia in saudi arabs. A study of 270 subjects. Ann Intern Med 1978, 88:1-6.
79. Brittenham G., Lozoff B., Harris J.W., Mayson S.M., Miller A., Huisman T.H. Sickle cell anemia and trait in southern India: further studies. Am J Hematol 1979, 6:107-123.
80. Poillon W.N., Kim B.C., Rodgers G.P., Noguchi C.T., Schechter A.N. Sparing effect of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S at physiologic ligand saturations. Proc Natl Acad Sci U S A 1993, 90:5039-5043.
81. Lemonne N., Charlot K., Waltz X., Ballas S.K., Lamarre Y., Lee K., et al. Hydroxyurea treatment does not increase blood viscosity and improves red blood cell rheology in sickle cell anemia. Haematologica Jul 2 2015, [pii: haematol.2015.130435].
82. Ballas S.K., Dover G.J., Charache S. Effect of hydroxyurea on the rheological properties of sickle erythrocytes in vivo. Am J Hematol 1989, 32:104-111.
83. Charache S., Terrin M.L., Moore R.D., Dover G.J., Barton F.B., Eckert S.V., et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the multicenter study of hydroxyurea in sickle cell anemia. N Engl J Med 1995, 332:1317-1322.
84. Green N.S., Barral S. Emerging science of hydroxyurea therapy for pediatric sickle cell disease. Pediatr Res 2014, 75:196-204.
85. Ware R.E. How I use hydroxyurea to treat young patients with sickle cell anemia. Blood 2010, 115:5300-5311.
86. Baskurt O.K., Temiz A., Meiselman H.J. Effect of superoxide anions on red blood cell rheologic properties. Free Radic Biol Med 1998, 24:102-110.
87. Akohoue S.A., Shankar S., Milne G.L., Morrow J., Chen K.Y., Ajayi W.U., et al. Energy expenditure, inflammation, and oxidative stress in steady-state adolescents with sickle cell anemia. Pediatr Res 2007, 61:233-238.
88. Aslan M., Thornley-Brown D., Freeman B.A. Reactive species in sickle cell disease. Ann N Y Acad Sci 2000, 899:375-391.
89. Hebbel R.P., Morgan W.T., Eaton J.W., Hedlund B.E. Accelerated autoxidation and heme loss due to instability of sickle hemoglobin. Proc Natl Acad Sci U S A 1988, 85:237-241.
90. Klings E.S., Farber H.W. Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease. Respir Res 2001, 2:280-285.
91. Rice-Evans C., Omorphos S.C., Baysal E. Sickle cell membranes and oxidative damage. Biochem J 1986, 237:265-269.
92. Sheng K., Shariff M., Hebbel R.P. Comparative oxidation of hemoglobins a and S. Blood 1998, 91:3467-3470.
93. Hierso R., Waltz X., Mora P., Romana M., Lemonne N., Connes P., et al. Effects of oxidative stress on red blood cell rheology in sickle cell patients. Br J Haematol 2014, 166:601-606.
94. Banerjee T., Kuypers F.A. Reactive oxygen species and phosphatidylserine externalization in murine sickle red cells. Br J Haematol 2004, 124:391-402.
95. Chaves M.A., Leonart M.S., do Nascimento A.J. Oxidative process in erythrocytes of individuals with hemoglobin S. Hematology 2008, 13:187-192.
96. Grau M., Friederichs P., Krehan S., Koliamitra C., Suhr F., Bloch W. Decrease in red blood cell deformability is associated with a reduction in RBC-NOS activation during storage. Clin Hemorheol Microcirc Jun 13 2014, 10.3233/CH-141850.
97. Kleinbongard P., Schulz R., Rassaf T., Lauer T., Dejam A., Jax T., et al. Red blood cells express a functional endothelial nitric oxide synthase. Blood 2006, 107:2943-2951.
98. Simmonds M.J., Detterich J.A., Connes P. Nitric oxide, vasodilation and the red blood cell. Biorheology 2014, 51:121-134.
99. Grau M., Pauly S., Ali J., Walpurgis K., Thevis M., Bloch W., et al. RBC-NOS-dependent S-nitrosylation of cytoskeletal proteins improves RBC deformability. PLoS One 2013, 8.
100. Grau M., Mozar A., Charlot K., Lamarre Y., Weyel L., Suhr F., et al. High red blood cell nitric oxide synthase activation is not associated with improved vascular function and red blood cell deformability in sickle cell anaemia. Br J Haematol 2015, 168:728-736.
101. Mozar A., Grau M., Lamarre Y., Weyel L., Suhr F., Collins B., et al. Red blood cell nitric oxide synthase activation is increased in patients with sickle cell hemoglobin C disease. Am J Hematol 2015, 90:E30-E32.
102. Bor-Kucukatay M., Wenby R.B., Meiselman H.J., Baskurt O.K. Effects of nitric oxide on red blood cell deformability. Am J Physiol Heart Circ Physiol 2003, 284:H1577-H1584.
103. Belanger A.M., Keqqi C., Kanias T., Gladwin M.T., Kim-Shapiro D.B. Effects of nitric oxide and its congeners on sickle red blood cell deformability. Transfusion Apr 23 2015, 10.1111/trf.13134.
104. Barodka V., Mohanty J.G., Mustafa A.K., Santhanam L., Nyhan A., Bhunia A.K., et al. Nitroprusside inhibits calcium-induced impairment of red blood cell deformability. Transfusion 2014, 54:434-444.
105. Bogdanova A., Makhro A., Wang J., Lipp P., Kaestner L. Calcium in red blood cells-a perilous balance. Int J Mol Sci 2013, 14:9848-9872.
106. Minniti C.P., Gorbach A.M., Xu D., Yi Hon Y., Delaney K.M., Seidel M., et al. Topical sodium nitrite for chronic leg ulcers in patients with sickle cell anaemia: a phase 1 dose-finding safety and tolerability trial. Lancet Haematol 2014, 1:e95-e103.
107. Nagaoka T., Yoshida A. Noninvasive evaluation of wall shear stress on retinal microcirculation in humans. Invest Ophthalmol Vis Sci 2006, 47:1113-1119.
108. Nicolete R., Rius C., Piqueras L., Jose P.J., Sorgi C.A., Soares E.G., et al. Leukotriene B4-loaded microspheres: a new therapeutic strategy to modulate cell activation. BMC Immunol 2008, 9:36.
109. Papaioannou T.G., Stefanadis C. Vascular wall shear stress: basic principles and methods. Hellenic J Cardiol 2005, 46:9-15.
110. Stoltz J.F. Hemorheology: pathophysiological significance. Acta Med Port 1985, 6:S4-13.
111. Wray D.W., Uberoi A., Lawrenson L., Richardson R.S. Heterogeneous limb vascular responsiveness to shear stimuli during dynamic exercise in humans. J Appl Physiol 2005, 99:81-86.